2.64
price down icon0.38%   -0.010
after-market Handel nachbörslich: 2.64
loading

Finanzdaten der Organogenesis Holdings Inc-Aktie (ORGO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
49.54%
225.61
150.86 101.00 86.69 115.18
Operating Expenses
24.73%
162.32
130.14 113.58 89.72 82.14
Benefits Costs and Expenses
25.04%
162.18
129.70 112.84 112.48 109.35
Costs And Expenses
25.04%
162.18
129.70 112.84 112.48 109.35
Operating Income/Loss
205.35%
63.29
20.73 -12.58 -26.75 6.242
Nonoperating Income/Loss
68.13%
0.138
0.433 0.742 0.963 -0.419
Income/Loss From Continuing Operations Before Tax
199.75%
63.43
21.16 -11.83 -25.78 5.823
Income Tax Expense/Benefit, Deferred
507.32%
15.63
-3.837 -1.026 -1.266 -2.198
Income Tax Expense/Benefit
4,947%
19.73
-0.407 -2.442 -6.94 -6.508
Income/Loss From Continuing Operations After Tax
102.62%
43.70
21.57 -9.392 -18.84 12.33
Net Income/Loss
102.62%
43.70
21.57 -9.392 -18.84 12.33
Preferred Stock Dividends And Other Adjustments
21.81%
8.578
7.042 - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.95%
0.059
126.88 126.85 126.30 132.58
Diluted Average Shares
97.27%
3.5693
130.85 133.93 126.30 133.93
Basic Earnings Per Share
154.55%
0.28
0.11 -0.10 -0.17 0.09
Diluted Earnings Per Share
145.45%
0.27
0.11 -0.10 -0.17 0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
21.81%
8.578
7.042 - - -
$22.94
price up icon 1.15%
drug_manufacturers_specialty_generic RGC
$23.23
price down icon 3.21%
drug_manufacturers_specialty_generic RDY
$14.13
price down icon 1.53%
$129.78
price up icon 1.57%
$13.51
price down icon 2.10%
$536.12
price up icon 0.62%
Kapitalisierung:     |  Volumen (24h):